Researchers: Keith Petrie and Kate MacKrill, University of Auckland. The purpose of this survey was to gather feedback from people about their experiences of changing venlafaxine brands during the 2017 funded brand switch. We wanted to better understand the impact of brand changes on people taking medicine and to gain insights to inform Pharmac brand change activities in the future.
This survey has now closed and is not accepting additional responses at this time.
Thank you for your interest in this survey, for more information about the venlafaxine brand switch please see the Pharmac page https://www.pharmac.govt.nz/medicines/my-medicine-has-changed/venlafaxine/